ACR Leaders at ECR 2026
ACR leaders showcased advances in radiology AI and global programs driving safe adoption, quality assurance and international collaboration.
Read moreACR Data Science Institute’s AI Central has been updated with a new PRO Platform manufacturer and two new products to the directory.
Aidoc Medical, Ltd. joined our AI Central PRO program this month and added their platform, Aidoc aiOS, to the directory. Aidoc aiOS helps health systems overcome the challenges of AI adoption with a single, unified medical AI platform.
AI Central PRO allows manufacturers to add additional information to their manufacturer and product profiles on AI Central to explain how their products work in an effort to improve patient care and make it easier to learn more. This gives radiologists a better understanding of how a product can best support their patients and workflows through supplemental material about each product developed by the manufacturer.
Aidoc Medical, Ltd. also have five products in our Transparent-AI program: BriefCase-Aortic Dissection Triage, BriefCase-Pneumothorax Triage, BriefCase-Pulmonary Embolism Triage, BriefCase-Rib Fracture Triage, and BriefCase-Intra-abdominal Free Gas Triage.
Transparent-AI is designed to increase transparency in imaging AI and help end users have better informed discussions and selection criteria when making decisions about which algorithm might be most appropriate for their local target population. The program consists of voluntarily provided data elements solicited from participating imaging AI manufacturers who currently have an FDA-cleared product in the U.S. market. Manufacturers who participate in this program will receive the Transparent-AI badge on their product listing.
Our AI Central directory has also been updated with two new products. This information is pulled directly from FDA 510K documents and updated by ACR staff. With this latest update, we see newly cleared FDA products designed for pediatric x-rays, chest CTs and prostate MR images.
New products include:
ACR Leaders at ECR 2026
ACR leaders showcased advances in radiology AI and global programs driving safe adoption, quality assurance and international collaboration.
Read moreACR Encourages Flexibility in HHS Information Blocking Rules
ACR urges HHS to maintain AI transparency rules and adopt a requestor‑preference exception to support patient‑directed access to health data.
Read moreACR Provides Policy Guidance to HHS on Clinical AI
ACR recommended stronger AI oversight, more research funding, and sustainable Medicare payment to support safe clinical AI adoption.
Read more